A peptide derived from acetylcholinesterase is a pivotal signalling molecule in neurodegeneration

Chemico-Biological Interactions

Volumn 157-158, Issue , 2005, Pages 211-218

  Greenfield, Susan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetylcholinesterase; Alpha 7 nicotinic receptor; Neurodegeneration; Peptide; Trophic toxic axis

Indexed keywords

ACETYLCHOLINESTERASE; AMINO ACID; CALCIUM; NICOTINIC RECEPTOR; PEPTIDE;

CALCIUM TRANSPORT; CONFERENCE PAPER; EXPOSURE; HUMAN; NERVE DEGENERATION; NONHUMAN; REGULATORY MECHANISM; TOXICITY; TROPHIC LEVEL;

ACETYLCHOLINESTERASE; ANIMALS; HUMANS; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; OOCYTES; PEPTIDE FRAGMENTS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; XENOPUS;

EID: 28744437927     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.10.032     Document Type: Conference Paper

References (27)

1. D. Aarsland, E. Tandberg, J.P. Larsen, and J.L. Cummings Frequency of dementia in Parkinson's disease Arch Neurol. 53 1996 538 542
2. S. Battaille, P. Portalier, P. Coulon, and J.P. Ternaux Influence of acetylcholinesterease on embryonic spinal rat motorneurones growth in culture: a quantitative morphometric study Eur. J. Neurosci. 10 1998 560 572
3. R.S. Broide, R.T. Robertson, and F.M. Leslie Regulation of α7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents J. Neurosci. 16 1996 2956 2971
4. C.L. Bon, and S.A. Greenfield Bioactivity of a peptide derived from acetylcholinesterase: electrophysiological characterisation in guinea-pig hippocampus Eur. J. Neurosci. 17 2003 1991 1995
5. D.B. Calne, A. Eisen, E. McGeer, and P. Spencer Alzheimer's disease, Parkinson's disease, and motor neurone disease: abiotrophic interaction between ageing and environment? Lancet 2 8515 1986 1067 1070
6. D.W. Choi Excitotoxic cell death J. Neurobiol. 23 1992 1261 1276
7. T. Day, and S.A. Greenfield A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms Neuroscience 111 2002 649 656
8. T. Day, and S.A. Greenfield A Peptide derived from AChE induces neuronal death Exp. Brain Res. 153 3 2003 334 342
9. T. Day, and S.A. Greenfield Bioactivity of a peptide derived from AChE in hippocampal organotypic cultures Exp. Brain Res. 155 2004 500 508
10. B.G.M. Dickie, A.M. Haris, and S.A. Greenfield Measurement of acetylcholinesterase secretion from ventral mesencephalic cultures as a means of assessing the dopaminergic neuronal population Neurosci. Res. Commun. 26 2000 103 111
11. S. Eimerl, and M. Schramm The quantity of calcium that appears to enhance neuronal death J. Neurochem. 62 1994 1223 1226
12. M. Gearing, J.A. Schneider, G.W. Rebeck, B.T. Hyman, and S.S. Mirra Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropatholigic correlates Neurology 45 1995 1985 1990
13. S.A. Greenfield The significance of dendritic release of transmitter and protein in the substantia nigra Neurochem. Int. 7 1985 887 901
14. S.A. Greenfield, and D.J. Vaux Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism Neuroscience 113 2002 485 492
15. S.A. Greenfield, T. Day, E.O. Mann, and I. Bermudez A novel peptide modulates alpha 7 nicotinic receptor responses: implications for a possible trophic-toxic mechanism within the brain J. Neurochem. 90 2004 325 331
16. S.A. Greenfield, M.R. Turner, L.L. Crouch, K.A. Whyte, S.J. Banner, C.E. Shaw, A novel test with potential for diagnosis and monitoring of amyotrophic lateral sclerosis? J. Neurol., Neurosurg. Psychiatry (2005) (submitted for pulication).
17. C. Holmes, S.A. Jones, T.C. Budd, and S.A. Greenfield Non-cholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neurons J. Neurosci. Res. 49 1997 207 218
18. C. Hulette, S. Mirra, W. Wilkinson, A. Heyman, G. Fillenbaum, and C. Clark The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease Neurology 45 1995 1991 1995
19. P.J. Massman, J. Sims, N. Cooke, L.J. Haverkamp, V. Appel, and S.H. Appel Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis J. Neurol. Neurosurg. Psychiatry 61 1996 450 455
20. R.G. Nagele, M.R. D'Andrea, W.J. Anderson, and H.Y. Wang Intracellular accumulation of beta-amyloid (1_42) in neurons is facilitated by the alpha 7 nicotinic acetylcholinesterase receptor in Alzheimer's disease Neurosci 110 2002 199 211
21. D. Rodriguez-Ithurralde, A. Maruri, and X. Rodriguez Motor neurone acetylcholinesterase release precedes neurotoxicity caused by systemic administration of excitatory amino acids and strychnine J. Neurol. Sci. 160 1998 S80 S86
22. M.N. Rossor Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core Br. Med. J. (Clin. Res. Ed.) 283 1981 1588 1590
23. P. Seguela, J. Wadiche, K. Dineleymiller, J.A. Dani, and J.W. Patrick Molecular cloning, functional-properties, and distribution of rat brain alpha 7 receptor - a nicotinic cation channel highly permeable to calcium J. Neurosci. 13 1993 596 604
24. H. Soreq, and S. Seidman Acetylcholinesterase - new roles for an old actor Nat. Rev. Neurosci. 2 2001 294 302
25. J.C. Vickers, T.C. Dickson, P.A. Adlard, H.L. Saunders, C.E. King, and G. McCormack The cause of neuronal degeneration in Alzheimer's disease Prog. Neurobiol. 60 2000 139 165
26. K. Whyte, and S.A. Greenfield Effects of acetylcholinesterase and butyrylcholinesterase on cell survival, neurite outgrowth, and voltage-dependent calcium currents of embryonic ventral mesencephalic neurons Exp. Neurol. 184 2003 496 509
27. N.J. Woolf Global and serial neurons from a hierarchical arranged interface proposed to underlie memory and cognition Neuroscience 74 1996 625 651